EMEA-001933-PIP01-16-M01

Key facts

Active substance
Autologous CD34+ cells transduced with lentiviral vector encoding the human beta-globin gene
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0236/2020
PIP number
EMEA-001933-PIP01-16-M01
Pharmaceutical form(s)
Dispersion for injection
Condition(s) / indication(s)
Treatment of beta-thalassemia
Route(s) of administration
Intraosseous use
Contact for public enquiries
Orchard Therapeutics (Europe) Ltd

E-mail: regulatory@orchard-tx.com
Tel.  +44 2038088286

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating